These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9516012)
21. First-trimester maternal serum alpha-fetoprotein and human chorionic gonadotropin screening for chromosome defects. Nebiolo L; Ozturk M; Brambati B; Miller S; Wands J; Milunsky A Prenat Diagn; 1990 Sep; 10(9):575-81. PubMed ID: 1702539 [TBL] [Abstract][Full Text] [Related]
22. Detection of fetal Turner syndrome with multiple-marker screening. Wenstrom KD; Williamson RA; Grant SS Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569 [TBL] [Abstract][Full Text] [Related]
23. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131 [TBL] [Abstract][Full Text] [Related]
24. The advantages of using triple-marker screening for chromosomal abnormalities. Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448 [TBL] [Abstract][Full Text] [Related]
25. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening. Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067 [TBL] [Abstract][Full Text] [Related]
26. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
27. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [TBL] [Abstract][Full Text] [Related]
28. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Pergament E; Stein AK; Fiddler M; Cho NH; Kupferminc MJ Obstet Gynecol; 1995 Aug; 86(2):255-8. PubMed ID: 7542379 [TBL] [Abstract][Full Text] [Related]
29. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551 [TBL] [Abstract][Full Text] [Related]
30. Making sense of maternal serum screening. Lindsay P Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377 [TBL] [Abstract][Full Text] [Related]
31. Screening of maternal serum for fetal Down's syndrome in the first trimester. Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983 [TBL] [Abstract][Full Text] [Related]
32. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964 [TBL] [Abstract][Full Text] [Related]
33. [Trisomy-21 screening using AFPplus in the eastern part of Switzerland]. Zimmermann R; Schmid W; Binkert F; Achermann J; Huch R; Huch A Schweiz Med Wochenschr; 1995 Jul; 125(26):1286-93. PubMed ID: 7541552 [TBL] [Abstract][Full Text] [Related]
34. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected? Christiaens GC; Hagenaars AM; Akkerman C; De France HF Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002 [TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotrophin and trisomy 18. Barkai G; Chaki R; Sochat M; Goldman B Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814 [TBL] [Abstract][Full Text] [Related]
36. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342 [TBL] [Abstract][Full Text] [Related]
37. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
38. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Burton BK; Prins GS; Verp MS Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522 [TBL] [Abstract][Full Text] [Related]
40. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome. Benn PA; Horne D; Briganti S; Greenstein RM Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]